Hyperion Defi (HYPD) Operating Expenses (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Operating Expenses of -$8.5 million for Q1 2026, down 378.71% year-over-year from $3.0 million in Q1 2025, and down 121.24% quarter-over-quarter from $40.0 million in Q4 2025.
Hyperion Defi (HYPD) Operating Expenses (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Operating Expenses for 10 consecutive years, with -$8.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 378.71% year-over-year to -$8.5 million; the TTM figure through Mar 2026 stood at $35.7 million (down 5.67% YoY), while the FY2025 annual figure was $47.2 million, up 5.27% from the prior year.
- Operating Expenses slipped to -$8.5 million in Q1 2026 per HYPD's latest filing, from $40.0 million in the prior quarter.
- Across five years, Operating Expenses topped out at $40.0 million in Q4 2025 and bottomed at -$8.5 million in Q1 2026.
- Historically, Operating Expenses has averaged $8.0 million across 5 years, with a median of $7.2 million in 2022.
- Annual changes were most pronounced in 2025 — Operating Expenses jumped 143.98% — and 2026, when it plunged 378.71%.
- Hyperion Defi's Operating Expenses stood at $5.4 million in 2022, then surged by 38.98% to $7.5 million in 2023, then surged by 119.35% to $16.4 million in 2024, then surged by 143.98% to $40.0 million in 2025, then sank by 121.24% to -$8.5 million in 2026.
- Business Quant data shows HYPD's Operating Expenses at -$8.5 million in Q1 2026, $40.0 million in Q4 2025, and -$4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 59.49 Bn | 54.36 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.02 Bn | 36.92 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.79 Bn | 27.48 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.26 Bn | 9.87 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.10 Bn | 26.26 Bn | - | 541.02 Mn |
| 10 | Hyperion Defi | 47.48 Mn | 37.84 Mn | 357,693.00 | -30.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30.65 Mn |
| Mar 31, 2026 | -8.49 Mn |
| Dec 31, 2025 | 39.96 Mn |
| Sep 30, 2025 | -4.13 Mn |
| Jun 30, 2025 | 8.35 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 16.38 Mn |
| Sep 30, 2024 | 7.20 Mn |
| Jun 30, 2024 | 11.22 Mn |
| Mar 31, 2024 | 10.07 Mn |
| Dec 31, 2023 | 7.47 Mn |
| Sep 30, 2023 | 6.51 Mn |
| Jun 30, 2023 | 5.96 Mn |
| Mar 31, 2023 | 5.46 Mn |
| Dec 31, 2022 | 5.37 Mn |
| Sep 30, 2022 | 7.23 Mn |
| Jun 30, 2022 | 7.12 Mn |
| Mar 31, 2022 | 7.19 Mn |
| Dec 31, 2021 | 6.95 Mn |
| Sep 30, 2021 | 5.93 Mn |